AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Letstart Tablet

Prescription Icon
Prescription Required

Marketer

Aarushi Healthcare Pvt Ltd

Salt Composition

Letrozole (2.5mg)

Overview Letstart Tablet

Postmenopausal women with breast cancer may find relief with Letstart Tablets. This medication can be administered independently or in conjunction with other therapies like surgery or radiotherapy. It's also indicated for advanced breast cancer to inhibit metastasis. Letstart Tablets can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage frequency is tailored to the specific treatment goal, determined by your doctor to manage symptoms effectively. Continuous use, as directed, is crucial. Common side effects include hot flushes, weariness, excessive perspiration, and elevated cholesterol. Report any concerning or severe side effects to your physician; management strategies are available. Prior to commencing treatment, inform your doctor of any prior liver or kidney conditions, or a history of osteoporosis. Complete disclosure of all other medications is essential, as interactions may reduce Letstart's efficacy or alter its function. Pregnant or breastfeeding women should consult their doctor. Baseline and ongoing blood tests to monitor vitamin D levels and bone density may be conducted during treatment.

Uses of Letstart Tablet

Managing breast cancer

Major Benefits of Letstart Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letstart Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Letstart Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letstart Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letstart Tablets can be consumed with or without food, although consistent timing is recommended.

How Letstart Tablet works:

Letstart tablets function as aromatase inhibitors, reducing the body's estrogen production—a key female hormone. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letstart Tablet may be taken with alcohol without adverse reactions.

PregnancyPregnancyUNSAFE

Using Letstart Tablet during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animals and humans indicates substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Letstart Tablets. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Letstart Tablets may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving while experiencing these effects is strongly discouraged.

KidneyKidneySAFE IF PRESCRIBED

The use of Letstart Tablet is considered safe for individuals with kidney disease, and no dosage modification is typically advised. Nevertheless, data on its use in patients with end-stage renal disease is scarce. Physician consultation is recommended.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Letstart Tablet. Dosage modification may be necessary; physician consultation is recommended.

What if you forget to take Letstart Tablet :

Should you forget a Letstart Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual schedule. Avoid taking a double dose.

Facts to Know About Letstart Tablet

LabelValue
Type of Compound Benzophenone-related compound
Potential for Dependence None.
Medication Classification Cancer medications

FAQs on Letstart Tablet

Aromatase inhibitor Letstart Tablets are typically indicated for managing breast cancer in postmenopausal women, including those whose menstruation ceased following surgery or chemotherapy.
Letstart Tablets function as an aromatase inhibitor, thereby decreasing estrogen levels. This classification stems from its mechanism of action: blocking aromatase, the enzyme responsible for estrogen synthesis. Because some breast cancers are fueled by estrogen ("estrogen-dependent cancers"), inhibiting estrogen production can hinder their growth.
For advanced breast cancer or cancer that has metastasized, Letstart Tablet should be administered until disease progression is observed. Following tamoxifen therapy or surgery, Letstart Tablet treatment should continue for five years or until recurrence, whichever occurs earlier. Alternatively, a sequential regimen of two years of Letstart Tablet followed by three years of tamoxifen may be employed.
Concurrent use of irbesartan and Letstart Tablet is permissible. Nevertheless, diligent blood pressure monitoring is advised, as Letstart Tablet can elevate blood pressure. Seek medical attention if blood pressure management proves challenging.
While rare, Letstart Tablet use has been associated with cataract formation. Therefore, immediate medical attention is advised if blurred vision or eye discomfort develops.
Experiencing this may indicate hot flashes, a frequent side effect of Letstart Tablet. These occur because of lower estrogen levels. Hot flashes typically lessen as your body adapts to Letstart Tablet. Nevertheless, for some, sweating and flushes might persist throughout treatment, subsiding only after several months. If this proves significantly disruptive, seek advice from your physician for potential management options.
Incidence of severe adverse reactions associated with Letstart Tablet is low. However, potential serious side effects may include stroke, angina, myocardial infarction, thromboembolic events, cataracts, osteoporosis, and severe dermatological reactions.
Treatment with Letstart Tablets can lead to bone thinning or loss (osteoporosis) resulting from reduced estrogen. Prior to, throughout, and following treatment, your physician might assess your bone mineral density to monitor for osteoporosis.
The Ministry of Health and Family Welfare designates Letstart Tablets solely for the induction of ovulation in women experiencing anovulatory infertility.
Letstart Tablet
126
MRP 146
13% off